|
|
|
Insider
Information: |
Conrades George N |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
715,877 |
|
Indirect Shares
|
686,347 |
|
|
Direct
Value |
$55,124,511 |
|
|
Indirect Value
|
$22,397,943 |
|
|
Total
Shares |
1,402,224 |
|
|
Total
Value |
$77,522,455 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-170.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cardinal Health Inc |
CAH |
Director |
2007-11-07 |
2,653 |
2005-11-02 |
1,792 |
Premium* |
|
Akamai Technologies Inc |
AKAM |
Director |
2018-05-20 |
482,957 |
2013-02-12 |
200,800 |
Premium* |
|
Oracle Corp |
ORCL |
Director |
2024-05-31 |
21,139 |
2009-01-14 |
0 |
Premium* |
|
Harley Davidson Inc |
HOG |
Director |
2009-02-27 |
52,573 |
2015-08-14 |
0 |
Premium* |
|
Ironwood Pharmaceuticals Inc |
IRWD |
Director |
2015-06-03 |
152,221 |
2015-06-03 |
483,755 |
Premium* |
|
Cyclerion Therapeutics, Inc. |
CYCN |
Director |
2019-04-01 |
4,334 |
2019-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
167 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ORCL |
Oracle Corp |
Director |
|
2017-09-29 |
4 |
S |
$48.25 |
$2,171,250 |
D/D |
(45,000) |
10,000 |
0 |
- |
|
AKAM |
Akamai Technologies Inc |
Director |
|
2018-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,519 |
482,957 |
0 |
- |
|
ORCL |
Oracle Corp |
Director |
|
2018-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,844 |
19,844 |
0 |
- |
|
CYCN |
Cyclerion Therapeutics, I... |
Director |
|
2019-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,421 |
2,421 |
0 |
- |
|
CYCN |
Cyclerion Therapeutics, I... |
Director |
|
2019-04-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
2,421 |
4,334 |
0 |
- |
|
ORCL |
Oracle Corp |
Director |
|
2019-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,465 |
32,309 |
0 |
- |
|
ORCL |
Oracle Corp |
Director |
|
2020-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,857 |
44,166 |
0 |
- |
|
ORCL |
Oracle Corp |
Director |
|
2021-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,509 |
50,675 |
0 |
- |
|
ORCL |
Oracle Corp |
Director |
|
2022-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,445 |
55,120 |
0 |
- |
|
ORCL |
Oracle Corp |
Director |
|
2023-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,866 |
22,486 |
0 |
- |
|
ORCL |
Oracle Corp |
Director |
|
2023-11-10 |
4 |
S |
$111.97 |
$260,334 |
D/D |
(2,325) |
20,161 |
0 |
% |
|
ORCL |
Oracle Corp |
Director |
|
2023-11-13 |
4 |
S |
$113.76 |
$264,494 |
D/D |
(2,325) |
17,836 |
0 |
% |
|
ORCL |
Oracle Corp |
Director |
|
2024-05-01 |
4 |
OE |
$42.02 |
$1,050,500 |
D/D |
25,000 |
42,836 |
0 |
- |
|
ORCL |
Oracle Corp |
Director |
|
2024-05-01 |
4 |
S |
$116.13 |
$2,903,190 |
D/D |
(25,000) |
17,836 |
0 |
% |
|
ORCL |
Oracle Corp |
Director |
|
2024-05-03 |
4 |
OE |
$42.02 |
$840,400 |
D/D |
20,000 |
37,836 |
0 |
- |
|
ORCL |
Oracle Corp |
Director |
|
2024-05-03 |
4 |
S |
$116.00 |
$2,320,000 |
D/D |
(20,000) |
17,836 |
0 |
% |
|
ORCL |
Oracle Corp |
Director |
|
2024-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,303 |
21,139 |
0 |
- |
|
167 Records found
|
|
Page 7 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|